Accuray Incorporated (ARAY)
ARAY Stock Price Chart
Explore Accuray Incorporated interactive price chart. Choose custom timeframes to analyze ARAY price movements and trends.
ARAY Company Profile
Discover essential business fundamentals and corporate details for Accuray Incorporated (ARAY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Feb 2007
Employees
987.00
Website
https://www.accuray.comCEO
Suzanne Winter
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
ARAY Financial Timeline
Browse a chronological timeline of Accuray Incorporated corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.08, while revenue estimate is $92.22M.
Earnings released on 13 Aug 2025
EPS came in at $0.01 falling short of the estimated $0.03 by -65.63%, while revenue for the quarter reached $127.54M , beating expectations by +37.22%.
Earnings released on 30 Apr 2025
EPS came in at -$0.01 surpassing the estimated -$0.05 by +80.00%, while revenue for the quarter reached $113.24M , missing expectations by -8.51%.
Earnings released on 5 Feb 2025
EPS came in at $0.02 surpassing the estimated -$0.01 by +300.00%, while revenue for the quarter reached $116.17M , beating expectations by +5.27%.
Earnings released on 6 Nov 2024
EPS came in at -$0.04 falling short of the estimated -$0.03 by -24.53%, while revenue for the quarter reached $101.55M , beating expectations by +4.10%.
Earnings released on 19 Sept 2024
EPS came in at $0.03 , while revenue for the quarter reached $134.29M .
Earnings released on 1 May 2024
EPS came in at -$0.06 falling short of the estimated -$0.01 by -380.00%, while revenue for the quarter reached $101.13M , missing expectations by -16.77%.
Earnings released on 31 Jan 2024
EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%, while revenue for the quarter reached $107.24M , beating expectations by +0.53%.
Earnings released on 7 Nov 2023
EPS came in at -$0.03 falling short of the estimated -$0.02 by -39.99%, while revenue for the quarter reached $103.89M , beating expectations by +6.42%.
Earnings released on 9 Aug 2023
EPS came in at -$0.03 falling short of the estimated -$0.01 by -400.00%, while revenue for the quarter reached $118.29M , missing expectations by -2.83%.
Earnings released on 26 Apr 2023
EPS came in at $0.01 surpassing the estimated $0.00 by +185.71%, while revenue for the quarter reached $118.06M , missing expectations by -3.11%.
Earnings released on 1 Feb 2023
EPS came in at -$0.02 falling short of the estimated -$0.02 by -25.00%, while revenue for the quarter reached $114.76M , beating expectations by +7.22%.
Earnings released on 2 Nov 2022
EPS came in at -$0.06 falling short of the estimated -$0.02 by -172.73%, while revenue for the quarter reached $96.49M , missing expectations by -3.45%.
Earnings released on 10 Aug 2022
EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%, while revenue for the quarter reached $110.02M , beating expectations by +4.47%.
Earnings released on 27 Apr 2022
EPS came in at -$0.01 surpassing the estimated -$0.06 by +83.33%, while revenue for the quarter reached $96.17M , beating expectations by +0.13%.
Earnings released on 26 Jan 2022
EPS came in at $0.00 , while revenue for the quarter reached $116.28M , beating expectations by +12.54%.
Earnings released on 3 Nov 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -75.13%, while revenue for the quarter reached $107.44M , beating expectations by +21.42%.
Earnings released on 11 Aug 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -54.56%, while revenue for the quarter reached $110.94M , meeting expectations.
Earnings released on 27 Apr 2021
EPS came in at -$0.00 falling short of the estimated -$0.00 by -100.48%, while revenue for the quarter reached $102.56M , beating expectations by +3.32%.
Earnings released on 27 Jan 2021
EPS came in at $0.05 surpassing the estimated $0.01 by +397.51%, while revenue for the quarter reached $97.46M , missing expectations by -75.31%.
Earnings released on 29 Oct 2020
EPS came in at $0.00 surpassing the estimated -$0.07 by +106.26%, while revenue for the quarter reached $85.33M , missing expectations by -46.14%.
ARAY Stock Performance
Access detailed ARAY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.